Skip to main content
Fig. 2 | Experimental Hematology & Oncology

Fig. 2

From: Efficacy and safety of rituximab in autoimmune and microangiopathic hemolytic anemia: a systematic review and meta-analysis

Fig. 2Fig. 2Fig. 2

Forest plot. a Overall response rate of rituximab in AIHA and MAHA. b Complete response rate of rituximab in AIHA and MAHA. c Relapse rate of rituximab in AIHA and MAHA. d Relative overall response rate of rituximab in AIHA and MAHA. e Relative complete response rate of rituximab in AIHA and MAHA. f Relative relapse rate of rituximab in AIHA and MAHA

Back to article page

Experimental Hematology & Oncology

ISSN: 2162-3619

Contact us